Binge Eating Disorder: Vyvanse

“Experts” claim this relatively new “disease” affects up to 5% of adults and almost 2% of children or almost 3 million Americans. It’s defined as eating too much, too fast and suffering embarrassment afterward. Shire Pharmaceuticals, the company behind popularizing the concept of B.E.D., seeks to stimulate sales of its drug Vyvanse as the sole F.D.A. authorized drug to treat this condition. Unfortunately this pro-drug morphs into amphetamine with all of its associated toxicities. Whether Vyvanse which is also promoted for ADHD represents an advance remains debatable.

Leave a Reply

Your email address will not be published.